Literature DB >> 2554218

Transient increase in ligand binding to quisqualate and kainate sites in cerebral cortex of immature rats.

S L Erdö1, J R Wolff.   

Abstract

The postnatal changes in the specific binding of [3H]kainate and [3H]AMPA (RS-alpha-amino-3-hydroxy-5-methyl-4-isoxasolopropionic acid, an agonist of quisqualate receptors) were studied in cerebral cortex of rats, aged 2-360 days. The binding of the two ligands was assayed in whole-tissue homogenates. Similar developmental time courses were found for kainate and AMPA binding, characterized by high perinatal levels, a further increase during the first few days after birth, an early maximum value around the age of one week, and a gradual decrease to adult values which were attained at an age of 3-4 weeks. As revealed by Scatchard analysis, the transient elevation of ligand binding was derived from an increased density of binding sites, which, in the case of AMPA, was accompanied also by an increase in binding affinity. The results indicate that, in the immature cerebral cortex, kainate and quisqualate receptors may play a role other than in synaptic transmission.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554218     DOI: 10.1016/0304-3940(89)90348-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

1.  Specific [3H]glutamate binding in the cerebral cortex and hippocampus of rats during development: effect of homocysteine-induced seizures.

Authors:  J Folbergrová; V Lisý; R Haugvicová; F Stastný
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

2.  Uneven distribution of excitatory amino acid receptors on ventral horn neurones of newborn rat spinal cord.

Authors:  K Onodera; A Takeuchi
Journal:  J Physiol       Date:  1991-08       Impact factor: 5.182

3.  Age-dependent anticonvulsant actions of perampanel and brivaracetam in the methyl-6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM) model of seizures in developing rats.

Authors:  Marko Culjat; Megan N Huizenga; Patrick A Forcelli
Journal:  Pharmacol Rep       Date:  2020-11-18       Impact factor: 3.024

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.